Privium Fund Management’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.12M | Hold |
432,760
| – | – | 0.24% | 30 |
|
|
2025
Q1 | $2.89M | Buy |
432,760
+35,110
| +9% | +$234K | 0.75% | 21 |
|
|
2024
Q4 | $5M | Buy |
397,650
+102,850
| +35% | +$1.29M | 1.13% | 19 |
|
|
2024
Q3 | $5.44M | Buy |
294,800
+43,820
| +17% | +$809K | 1.35% | 21 |
|
|
2024
Q2 | $4.96M | Buy |
250,980
+15,930
| +7% | +$315K | 1.27% | 23 |
|
|
2024
Q1 | $6.33M | Buy |
235,050
+2,000
| +0.9% | +$53.9K | 1.69% | 18 |
|
|
2023
Q4 | $6.87M | Buy |
233,050
+89,700
| +63% | +$2.65M | 1.92% | 16 |
|
|
2023
Q3 | $2.94M | Buy |
143,350
+84,000
| +142% | +$1.72M | 0.87% | 29 |
|
|
2023
Q2 | $1.19M | Hold |
59,350
| – | – | 0.34% | 44 |
|
|
2023
Q1 | $1.02M | Hold |
59,350
| – | – | 0.34% | 39 |
|
|
2022
Q4 | $1.16M | Buy |
59,350
+9,600
| +19% | +$187K | 0.44% | 33 |
|
|
2022
Q3 | $698K | Buy |
49,750
+25,000
| +101% | +$351K | 0.25% | 50 |
|
|
2022
Q2 | $341K | Buy |
+24,750
| New | +$341K | 0.11% | 69 |
|